The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation

scientific article published in June 2008

The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/SLA.0B013E31816FFAB6XXX
P698PubMed publication ID18520234

P2093author name stringChung Mau Lo
Sheung Tat Fan
Kwan Man
Qiao Cheng
Kevin T Ng
Irene O Ng
Chris K Sun
Jiang Wei Xiao
Bai Shun Sun
P2860cites workRapamycin attenuates liver graft injury in cirrhotic recipient--the significance of down-regulation of Rho-ROCK-VEGF pathwayQ56750684
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectliver transplantationQ1368191
neoplastic invasivenessQ112498967
P304page(s)1049-1057
P577publication date2008-06-01
P1433published inAnnals of SurgeryQ4767866
P1476titleThe significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation
P478volume247

Reverse relations

cites work (P2860)
Q26749857A review of current status of living donor liver transplantation
Q37636484Beyond Milan criteria--chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis
Q48106523Does the Pringle maneuver affect survival and recurrence following surgical resection for hepatocellular carcinoma? A western series of 441 patients
Q90236683Does the intermittent Pringle maneuver affect the recurrence following surgical resection for hepatocellular carcinoma? A systematic review
Q41002670Donor miR-196a-2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population
Q48329517Dynamic Volume Assessment of Hepatocellular Carcinoma in Rat Livers Using a Clinical 3T MRI and Novel Segmentation.
Q37190186Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
Q28651675Effect of liver regeneration on malignant hepatic tumors
Q34365785Effect of the pringle maneuver on tumor recurrence of hepatocellular carcinoma after curative resection (EPTRH): a randomized, prospective, controlled multicenter trial
Q34182635FTY720 suppresses liver tumor metastasis by reducing the population of circulating endothelial progenitor cells
Q34764430Genomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validation
Q47114724Glutathione Peroxidase 3 Delivered by hiPSC-MSCs Ameliorated Hepatic IR Injury via Inhibition of Hepatic Senescence
Q39548324Growth of hepatocellular carcinoma in the regenerating liver
Q34610682Impact of hepatic arterial reconstruction on orthotopic liver transplantation in the rat.
Q26766049Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients
Q40597524Impact of operative and peri-operative factors on the long-term prognosis of primary liver cancer patients undergoing hepatectomy
Q33710669Inhibition of transforming growth factor-beta/Smad signaling improves regeneration of small-for-size rat liver grafts
Q41017463Interferon-gamma inducible protein 10 (IP10) induced cisplatin resistance of HCC after liver transplantation through ER stress signaling pathway
Q36154069Intermittent hepatic inflow occlusion during partial hepatectomy for hepatocellular carcinoma does not shorten overall survival or increase the likelihood of tumor recurrence
Q36962089Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome
Q89953527Living vs. deceased-donor liver transplantation for patients with hepatocellular carcinoma
Q34263346Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma
Q40778578Longer duration of the Pringle maneuver is associated with hepatocellular carcinoma recurrence following curative resection
Q40235716Postoperative peak serum C-reactive protein is a predictor of outcome following liver transplantation for hepatocellular carcinoma
Q37972812Prognostic indicators for tumor recurrence after liver transplantation in hepatocellular carcinoma and related molecular targeted therapy
Q45789352Protective effects of simultaneous splenectomy on small-for-size liver graft injury in rat liver transplantation
Q37317375Repressor and activator protein accelerates hepatic ischemia reperfusion injury by promoting neutrophil inflammatory response
Q34264788Salvage liver transplantation is a reasonable option for selected patients who have recurrent hepatocellular carcinoma after liver resection
Q47189438Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria
Q37614646Small-for-size liver graft injury--impact on tumor behavior.
Q36937325Smaller grafts do not imply early recurrence in recipients transplanted for hepatocellular carcinoma: A Chinese experience
Q54989355Surgical Treatment of Hepatocellular Carcinoma.
Q27300764The Clinical Significance and Potential Therapeutic Role of GPx3 in Tumor Recurrence after Liver Transplantation.
Q50763246The impact of posthepatectomy liver failure on the recurrence of hepatocellular carcinoma.
Q38259414The role of adult living donor liver transplantation and recent advances
Q52593728Transcriptome Analysis of Acute Phase Liver Graft Injury in Liver Transplantation.

Search more.